|
|
|
Volumn 91, Issue 5, 1996, Pages 1050-1051
|
|
New options for spontaneous bacterial prophylaxis: Costly or cost effective?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CIPROFLOXACIN;
COTRIMOXAZOLE;
NORFLOXACIN;
PLACEBO;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
ALCOHOL LIVER CIRRHOSIS;
ANTIBIOTIC PROPHYLAXIS;
BACTERIAL INFECTION;
BACTERIAL PERITONITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST BENEFIT ANALYSIS;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
ESCHERICHIA COLI;
HEPATITIS;
HIGH RISK PATIENT;
HUMAN;
LIVER CIRRHOSIS;
MAJOR CLINICAL STUDY;
NOTE;
PRIMARY BILIARY CIRRHOSIS;
PRIORITY JOURNAL;
STAPHYLOCOCCUS AUREUS;
TREATMENT OUTCOME;
ANTI-INFECTIVE AGENTS;
BACTERIAL INFECTIONS;
CIPROFLOXACIN;
DOUBLE-BLIND METHOD;
HUMANS;
PERITONITIS;
PROSPECTIVE STUDIES;
|
|
EID: 0029946069
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
